MRNA

Moderna (MRNA)

Moderna Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MRNA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	02 : 41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/05/14	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/05/11	05 : 43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/05/09	20 : 53	IH Market News	Bain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More News	NASDAQ:MRNA	Moderna Inc
2024/05/08	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/04/24	20 : 28	IH Market News	Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News	NASDAQ:MRNA	Moderna Inc
2024/04/10	20 : 13	IH Market News	Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News	NASDAQ:MRNA	Moderna Inc
2024/03/12	05 : 08	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:MRNA	Moderna Inc
2024/03/11	22 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/09	05 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/03/07	05 : 13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/03/06	07 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/06	07 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/05	05 : 32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/03/05	05 : 25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/03/02	07 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/02	07 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/01	07 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/03/01	06 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/03/01	06 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/01	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/01	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/03/01	06 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/03/01	06 : 15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/02/27	23 : 14	IH Market News	U.S. Stocks May Lack Direction Following Yesterday’s Modest Pullback	NASDAQ:MRNA	Moderna Inc
2024/02/24	06 : 21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MRNA	Moderna Inc
2024/02/24	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/02/23	05 : 39	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/02/22	20 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNA	Moderna Inc
2024/02/22	20 : 05	IH Market News	U.S. Futures Surge on Nvidia’s Stellar Performance, Global Markets Respond Positively	NASDAQ:MRNA	Moderna Inc